Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Grand Shuyang Life Sciences (chengdu) Co., Ltd.

Clinical trials sponsored by Grand Shuyang Life Sciences (chengdu) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New IVIG treatment aims to boost platelets in ITP patients Results expected Dec 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New IVIG treatment aims to boost platelets in ITP patients

    Disease control Recruiting now

    This Phase 3 trial tests a human immunoglobulin (IVIG) given intravenously for 5 days to adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risk. The study will enroll 36 participants in Turkey to see if the…

    Phase 3 • Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd. • Aim: Disease control

    Last updated Jun 27, 2026 12:05 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space